These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 31804792
41. Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents. Bianchera A, Buttini F, Bettini R. Expert Opin Ther Pat; 2020 Dec; 30(12):983-1000. PubMed ID: 33078643 [Abstract] [Full Text] [Related]
42. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. Chu Q, Xu H, Gao M, Guan X, Liu H, Deng S, Huo X, Liu K, Tian Y, Ma X. Int J Nanomedicine; 2016 Dec; 11():449-63. PubMed ID: 26869788 [Abstract] [Full Text] [Related]
43. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers. Weldrick PJ, Hardman MJ, Paunov VN. ACS Appl Mater Interfaces; 2019 Nov 27; 11(47):43902-43919. PubMed ID: 31718141 [Abstract] [Full Text] [Related]
45. Lipid Shell-Enveloped Polymeric Nanoparticles with High Integrity of Lipid Shells Improve Mucus Penetration and Interaction with Cystic Fibrosis-Related Bacterial Biofilms. Wan F, Nylander T, Klodzinska SN, Foged C, Yang M, Baldursdottir SG, M Nielsen H. ACS Appl Mater Interfaces; 2018 Apr 04; 10(13):10678-10687. PubMed ID: 29473725 [Abstract] [Full Text] [Related]
47. Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin. Müller L, Murgia X, Siebenbürger L, Börger C, Schwarzkopf K, Sewald K, Häussler S, Braun A, Lehr CM, Hittinger M, Wronski S. J Antimicrob Chemother; 2018 Oct 01; 73(10):2762-2769. PubMed ID: 29982453 [Abstract] [Full Text] [Related]
48. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles. Lababidi N, Montefusco-Pereira CV, de Souza Carvalho-Wodarz C, Lehr CM, Schneider M. Eur J Pharm Biopharm; 2020 Dec 01; 157():200-210. PubMed ID: 33222771 [Abstract] [Full Text] [Related]
49. Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer. Gao M, Xu H, Bao X, Zhang C, Guan X, Liu H, Lv L, Deng S, Gao D, Wang C, Tian Y. Life Sci; 2016 Nov 15; 165():63-74. PubMed ID: 27640889 [Abstract] [Full Text] [Related]
50. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro. Bahamondez-Canas TF, Zhang H, Tewes F, Leal J, Smyth HDC. Mol Pharm; 2018 Apr 02; 15(4):1643-1652. PubMed ID: 29514003 [Abstract] [Full Text] [Related]
51. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Zhu H, Chen H, Zeng X, Wang Z, Zhang X, Wu Y, Gao Y, Zhang J, Liu K, Liu R, Cai L, Mei L, Feng SS. Biomaterials; 2014 Feb 02; 35(7):2391-400. PubMed ID: 24360574 [Abstract] [Full Text] [Related]
52. Ultrasound-Activatable Phase-Shift Nanoparticle as a Targeting Antibacterial Agent for Efficient Eradication of Pseudomonas aeruginosa Biofilms. Xin L, Zhang C, Chen J, Jiang Y, Liu Y, Jin P, Wang X, Wang G, Huang P. ACS Appl Mater Interfaces; 2022 Oct 26; 14(42):47420-47431. PubMed ID: 36222290 [Abstract] [Full Text] [Related]
53. Nanoparticle (star polymer) delivery of nitric oxide effectively negates Pseudomonas aeruginosa biofilm formation. Duong HT, Jung K, Kutty SK, Agustina S, Adnan NN, Basuki JS, Kumar N, Davis TP, Barraud N, Boyer C. Biomacromolecules; 2014 Jul 14; 15(7):2583-9. PubMed ID: 24915286 [Abstract] [Full Text] [Related]
55. A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy. Liu H, Gao M, Xu H, Guan X, Lv L, Deng S, Zhang C, Tian Y. Pharm Res; 2016 Jan 14; 33(1):217-36. PubMed ID: 26334502 [Abstract] [Full Text] [Related]
56. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase). Deacon J, Abdelghany SM, Quinn DJ, Schmid D, Megaw J, Donnelly RF, Jones DS, Kissenpfennig A, Elborn JS, Gilmore BF, Taggart CC, Scott CJ. J Control Release; 2015 Jan 28; 198():55-61. PubMed ID: 25481442 [Abstract] [Full Text] [Related]
57. Inhalable mucin-permeable nanomicelles deliver antibiotics for effective treatment of chronic pneumonia. Jiang Z, Huo S, Qiao L, Lin P, Fu L, Wu Y, Li W, Bian C, Li Y, Li N, Cheng H, Nie X, Ding S. J Mater Chem B; 2024 Aug 28; 12(34):8465-8476. PubMed ID: 39109448 [Abstract] [Full Text] [Related]
58. Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis. Porsio B, Cusimano MG, Schillaci D, Craparo EF, Giammona G, Cavallaro G. Biomacromolecules; 2017 Dec 11; 18(12):3924-3935. PubMed ID: 29111673 [Abstract] [Full Text] [Related]
59. Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles. Sahin A, Spiroux F, Guedon I, Arslan FB, Sarcan ET, Ozkan T, Colak N, Yuksel S, Ozdemir S, Ozdemir B, Akbas S, Ultav G, Aktas Y, Capan Y. Pharmazie; 2017 Sep 01; 72(9):525-528. PubMed ID: 29441979 [Abstract] [Full Text] [Related]
60. Surface-Adaptive, Antimicrobially Loaded, Micellar Nanocarriers with Enhanced Penetration and Killing Efficiency in Staphylococcal Biofilms. Liu Y, Busscher HJ, Zhao B, Li Y, Zhang Z, van der Mei HC, Ren Y, Shi L. ACS Nano; 2016 Apr 26; 10(4):4779-89. PubMed ID: 26998731 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]